Anesthesia is a medical term which means insensitivity to pain. Anesthesia is widely used during surgical procedures to render patients unconscious. Spinal-epidural anesthesia is a type of anesthesia for almost any patient of any age. It is injected near the spinal cord and nerve roots. It helps in blocking the pain in the entire body. Spinal-epidural anesthesia combines the rapidity of onset and predictability of a spinal block, with the ability to modify and extend the block through an epidural. Combined spinal and epidural anesthesia technique also allows for post-operative pain relief via epidural patient controlled anesthesia. New surgical procedures have increased the life expectancy in individuals. The geriatric population is highly prone to degenerative diseases and chronic illnesses have increased number of surgeries and therapeutics performed annually, worldwide.
Distinct advantages of combined spinal-epidural anesthesia over general anesthesia such as reduced post anesthesia discomfort as compared to general anesthesia such as nausea, dryness of respiratory tract, and avoidance of other general anesthesia complications. Bronchospasm, trauma to lips, pharynx, vocal cords, prolonged paralysis, and malignant hyperthermia, are some of the reasons leading to increasing patient compliance and growing adoption of the combined spinal-epidural anesthesia set among healthcare providers around the world. Increase in prevalence of spinal cord injury is expected to propel the market during the forecast period. According to the National Spinal Cord Injury Statistical Center, an estimated 282,000 people in the U.S. lived with spinal cord injury in 2016 and the annual incidence of spinal cord injury (SCI) is approximately 17,000 new SCI cases each year.
The global combined spinal-epidural anesthesia sets market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be categorized into kits (trays and sets), needles, catheters, monitoring systems, and accessories. Based on application, the global combined spinal-epidural anesthesia sets market can be classified into hip replacement surgery, hysterectomy, knee surgery, cesarean section, emergency cesarean section, femur fracture, and others. In terms of end-user, the market can be divided into hospitals, clinics, ambulatory surgical centers, and others.
Geographically, the global combined spinal-epidural anesthesia sets market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 owing to increase in the number of surgical procedures performed by combined spinal-epidural anesthesia sets along with rise in patient compliance, new product and techniques being introduced in the market by major players, and growing demand for combined spinal-epidural anesthesia products from patients and health care providers. According to the American Academy of Orthopedic Surgeons (AAOS), in 2012, an estimated 1.5 million orthopedic or musculoskeletal surgeries were performed in the U.S., which included total hip replacement, spinal fusion, and total knee replacement. Europe is expected to be the second largest market in terms of revenue and the market is expected to grow during the forecast period due to increase in adoption of technologically advanced products and rise in incidence of sports injuries. According to the European Commission, annually, about 6.1 million people are being treated in hospitals for a sports injury. Of these about 7% (or 420,000 cases) have to be admitted for further treatment. Asia Pacific is expected to register high growth from 2017 to 2025, due to factors such as increase in prevalence of orthopedic and sports injuries, large and aging patient population, and growing awareness and adoption of combined spinal-epidural anesthesia sets in the region.
Key players operating in the global combined spinal-epidural anesthesia sets market include B. Braun Melsungen AG, Becton, Dickinson and Company, PAJUNK GmbH, Smiths Medical, Hull Anesthesia, and Teleflex Incorporated.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.